Sandoz, the generic drug business of Novartis has agreed to acquire the Japanese business of Aspen Global Incorporated (AGI), a fully owned subsidiary of Aspen Pharmacare in a deal valued up to €400 million, as per the latest pharma acquisition news. The acquisition includes shares in Aspen Japan and associated assets held by the South […]
Continue reading …US biopharma company Amgen has signed an all-cash deal to acquire a 20.5% stake in Chinese biotech company BeiGene for about $2.7 billion, as per the latest pharma acquisition news. The Beijing-based BeiGene is a research-based, oncology-focused biotechnology company, which is engaged in developing molecularly targeted and immuno-oncology drug candidates for cancer treatment. The transaction […]
Continue reading …NuChem Therapeutics has wrapped up the acquisition of Amplia Pharmatek, a Quebec-based drug discovery and development contract research organization (CRO) with a focus on biology. Based in Montreal, NuChem Therapeutics too is a drug discovery and development CRO. The company specializes in synthetic and medicinal chemistry services. Amplia Pharmatek, on the other hand, is a […]
Continue reading …Alexion acquisition of Achillion : Alexion Pharmaceuticals has agreed to acquire rival US pharma company Achillion Pharmaceuticals for about $930 million in an all-cash deal as per the latest pharma acquisition news. Achillion is a clinical-stage biopharma company, which is engaged in developing oral small molecule Factor D inhibitors for the treatment of people with […]
Continue reading …Sobi acquisition of Dova Pharmaceuticals : Swedish Orphan Biovitrum (Sobi) has signed a deal worth up to $915 million to acquire Dova Pharmaceuticals, a US pharma company, in a move to become a major player in hematology and orphan diseases and also for expanding its footprint in the US. Shareholders of Dova Pharmaceuticals will be […]
Continue reading …Currax Pharmaceuticals, a specialty biopharma company having branded and generic drug businesses, has acquired Nalpropion Pharmaceuticals for an undisclosed price, as per the latest pharma acquisition news. Through the acquisition, Currax gains the global rights to CONTRAVE (naltrexone HCl and bupropion HCl extended release), a prescribed weight-loss drug in the US, which has patent protection till […]
Continue reading …Lundbeck acquisition of Alder BioPharmaceuticals : Danish pharma company H. Lundbeck has entered into a definitive agreement to acquire Alder BioPharmaceuticals, a US clinical-stage pharma development company, in a transaction valued at up to $1.95 billion in cash. Alder BioPharmaceuticals is engaged in discovering, development and commercialization of novel therapeutic antibodies for the preventive treatment […]
Continue reading …Mindmed acquisition of 18-MC : Canada-based Mind Medicine (Mindmed) has acquired opioid addiction drug candidate 18-MC from Savant HWP for an undisclosed price, as per the latest pharma acquisition news. 18-MC, which is derived from ibogaine – a natural psychedelic substance, is being developed for addressing the opioid crisis and other types of addiction. The […]
Continue reading …Castle Creek acquisition of Fibrocell : Castle Creek Pharmaceutical Holdings (CCP Holdings) has agreed to acquire Fibrocell Science, a cell and gene therapy company engaged in developing autologous cell-based therapies for skin and connective tissue disorders. Financial terms of the deal were not disclosed, as per the latest pharma industry news. CCP Holdings is a […]
Continue reading …Aytu acquisition of Innovus : Colorado-based specialty pharma company Aytu BioScience has agreed to acquire Innovus Pharmaceuticals in a deal worth up to $24 million, as per the latest pharma acquisition news. Headquartered in California, Innovus Pharmaceuticals is an over the counter (OTC) consumer goods and specialty pharmaceutical company. On the other hand, Aytu BioScience […]
Continue reading …